No Data
No Data
FSD Pharma Wins Court Judgment Against Former CEO, Dr. Raza Bokhari
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting
FSD Pharma Signs Agreement With Applied Science And Performance Institute To Conduct A Clinical Trial In The U.S. To Assess The Safety And Efficacy Of 'Unbuzzd' In An Induced State Of Alcohol Intoxication
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" of the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the trea
FSD Pharma Edging Up In US Premarket Trade As Signs Agreement With INGENu CRO
FSD Pharma Inc. (NASDAQ and CSE:HUGE), a biopharmaceutical company, was at last look up 1.4% in US premarket trade after announcing Wednesday that through its subsidiary, HUGE Biopharma Australia Pty
FSD Pharma Brief: Says Court of Appeal Dismissed Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million
07:10 AM EST, 02/06/2024 (MT Newswires) -- FSD Pharma Brief: Says Court of Appeal Dismissed Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million
FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus
FSD Pharma Inc. (HUGE.CSE) over the holiday weekend announced that, further to its November 6 press release, and in order to replace its prior base shelf prospectus that expired, it has filed and obta
FSD Pharma Inc. Announces Closing of Private Placement
TORONTO, ON / ACCESSWIRE / December 5, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (the "Company" or "FSD"), is pleased to announce that, further to its news release on November 27, 2023,